Inventors:
Kevin Slawin - Houston TX, US
Shahrokh Shariat - Dallas TX, US
Seth Lerner - Houston TX, US
International Classification:
G01N033/574
Abstract:
A method to diagnose, stage and predict prognosis of bladder cancer patients is provided, e.g., using TGF-1, IL-6, IL-6sR, uPA, uPAR and IGFBP-3. These markers, and potentially others, in combination with standard clinical and pathologic features, may be used to create a nomogram that would be useful for managing bladder cancer patients.